Results 291 to 300 of about 4,582,351 (335)
Some of the next articles are maybe not open access.
British Journal of Hospital Medicine, 2008
Every junior doctor will have to prescribe some form of anticoagulation therapy for their patients. Foundation year 1 doctors should be familiar with the use of warfarin and heparin as anticoagulants, and be able to prescribe them appropriately, safely and effectively. The use of these drugs is outlined here.
R, Shakur +3 more
openaire +2 more sources
Every junior doctor will have to prescribe some form of anticoagulation therapy for their patients. Foundation year 1 doctors should be familiar with the use of warfarin and heparin as anticoagulants, and be able to prescribe them appropriately, safely and effectively. The use of these drugs is outlined here.
R, Shakur +3 more
openaire +2 more sources
Journal of Cardiovascular Pharmacology, 2018
Background: At present, it is considered that atrial fibrillation (AF) is a risk factor for cognitive impairment and dementia. It is independent of stroke, but the relationship between anticoagulant drugs and cognitive function in patients with AF is ...
Wenke Cheng +3 more
semanticscholar +1 more source
Background: At present, it is considered that atrial fibrillation (AF) is a risk factor for cognitive impairment and dementia. It is independent of stroke, but the relationship between anticoagulant drugs and cognitive function in patients with AF is ...
Wenke Cheng +3 more
semanticscholar +1 more source
Anticoagulation Therapy in Children
Seminars in Thrombosis and Hemostasis, 2003Thromboembolic events (TEs) in children are rare but are becoming a recognized cause of morbidity and mortality, particularly in children with serious underlying primary conditions such as congenital heart disease, cancer, or prematurity. Neonates, infants, and adolescents are most at risk for developing TEs among children, and the presence of a ...
Anthony K.C. Chan, Shoshana Revel-Vilk
openaire +6 more sources
Anticoagulation clinics and the monitoring of anticoagulant therapy
International Journal of Cardiology, 1988Patients attending an anticoagulation clinic were studied to delineate predisposing risk factors for bleeding and thromboembolic episodes. Seventy-three patients were observed for a total of 921.8 patient-treatment months. The mean duration of treatment was 12.6 months (range 3-36 months).
Richard Charney +3 more
openaire +3 more sources
The evolution of anticoagulant therapy.
Blood transfusion = Trasfusione del sangue, 2016Arterial and venous thromboembolism are leading causes of morbidity and mortality around the world. For almost 70 years, heparins (unfractionated heparin and low molecular weight heparins) and vitamin K antagonists have been the leading therapeutic ...
M. Franchini +3 more
semanticscholar +1 more source
Anticoagulation Therapy in Children [PDF]
Seminars in Thrombosis and Hemostasis, 2017 AbstractVenous thromboembolism (VTE) is very uncommon in children and adolescents compared with older adults, though its incidence has significantly increased over the past two decades. Given the rarity of the condition, the data on pediatric VTE lag behind the adult experience and consequently the management of VTE in children is, in large part ...
openaire +2 more sources
Anticoagulant therapy with ancrod
Critical Reviews in Oncology/Hematology, 19935.7. 5.8 ......... . . Treatment of venous thromboembolism 5.1.1. Deep venous thrombosis 5.1.2. Pulmonaryembolus Prophylaxis of venous thromboembolism Other venous thrombotic disorders Treatment of arterial thromboembolism 5.4.
Jeffrey S. Ginsberg, R.L. Soutar
openaire +3 more sources
Pharmacologic Therapies in Anticoagulation
Medical Clinics of North America, 2016Anticoagulants are beneficial for prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation. The development of target-specific oral anticoagulants is changing the landscape of anticoagulation therapy and created growing interest on this subject.
Joyce E. Wipf, Joana Lima Ferreira
openaire +3 more sources